| Age category | |||||
---|---|---|---|---|---|---|
25–64 years | 65–74 years | 75–84 years | ||||
OR [95Â % CI] | p Value | OR [95Â % CI] | p Value | OR [95Â % CI] | p Value | |
Total sample (n = 3452)a | (n = 1324) | (n = 1077) | (n = 1051) | |||
 Sex (women vs. men) | 1.28 [0.80–2.06] | 0.30 | 1.80 [1.24–2.61] | 0.002 | 1.38 [1.03–1.85] | 0.03 |
 Type of AMI (NSTEMI vs. STEMI) | 3.07 [1.81–5.20] | <0.0001 | 2.54 [1.59–4.05] | <0.0001 | 2.36 [1.59–3.51] | <0.0001 |
 Type of AMI (BBB vs. STEMI) | 4.22 [1.76–10.1] | 0.001 | 2.01 [1.05–3.84] | 0.03 | 2.60 [1.58–4.26] | 0.001 |
 Prior stroke (yes vs. no) | 2.97 [1.40–6.30] | 0.005 | 1.91 [1.17–3.13] | 0.01 | 1.87 [1.27–2.75] | 0.002 |
 Renal dysfunction (yes vs. no) | 2.27 [1.06–4.90] | 0.04 | 1.59 [1.03–2.45] | 0.04 | 1.35 [0.97–1.87] | 0.07 |
 Prior MI (yes vs. no) | 2.08 [1.27–3.41] | 0.004 | 2.00 [1.35–2.95] | 0.001 | 1.27 [0.89–1.81] | 0.18 |
 LVEF (LVEF ≤ 30 % vs. LVEF > 30 %) | 3.28 [1.60–6.71] | 0.001 | 1.85 [1.02–3.35] | 0.04 | 2.02 [1.30–3.14] | 0.002 |
 LVEF (LVEF n/mb vs. LVEF > 30 %) | 6.58 [4.05–10.7] | <0.0001 | 5.03 [3.32–7.63] | <0.0001 | 6.10 [4.27–8.73] | <0.0001 |
 History of hyperlipidemia (yes vs. no) | 0.52 [0.34–0.80] | 0.003 | 0.63 [0.44–0.90] | 0.01 | 0.67 [0.49–0.91] | 0.01 |
 History of COPD (yes vs. no) | 1.89 [0.87–4.13] | 0.11 | 2.26 [1.34–3.81] | 0.002 | 0.83 [0.50–1.39] | 0.48 |
 Peak serum CPK level (U/l) (continuous) | 1.00 [1.00–1.00] | 0.003 | 1.00 [1.00–1.00] | 0.04 | 1.00 [1.00–1.00] | <0.0001 |
STEMI (n = 1292) | (n = 625) | (n = 369) | (n = 298) | |||
 Sex (women vs. men) | n/ac | 2.35 [1.06–5.21] | 0.04 | n/ac | ||
 Prior stroke (yes vs. no) | 11.2 [2.58–48.7] | 0.001 | n/ac | n/ac | ||
 LVEF (LVEF ≤ 30 % vs. LVEF > 30 %) | 3.71 [1.01–13.6] | 0.05 | 2.36 [0.74–7.54] | 0.15 | 1.53 [0.58–4.03] | 0.39 |
 LVEF (LVEF n/mb vs. LVEF > 30 %) | 4.13 [1.22–14.0] | 0.02 | 3.90 [1.30–11.7] | 0.02 | 13.0 [5.72–29.3] | <0.0001 |
NSTEMI (n = 1838) | (n = 647) | (n = 603) | (n = 588) | |||
 Sex (women vs. men) | n/ac | 1.63 [1.04–2.53] | 0.03 | n/ac |  | |
 Prior stroke (yes vs. no) | n/ac | n/ac | 2.15 [1.34–3.46] | 0.002 | ||
 Renal dysfunction (yes vs. no) | 2.76 [1.18–6.45] | 0.02 | 1.80 [1.09–2.99] | 0.02 | n/ac | |
 Prior MI (yes vs. no) | 1.81 [1.03–3.18] | 0.04 | 2.04 [1.30–3.21] | 0.002 | n/ac | |
 LVEF (LVEF ≤ 30 % vs. LVEF > 30 %) | 3.08 [1.15–8.22] | 0.03 | 1.88 [0.86–4.13] | 0.12 | 3.19 [1.75–5.80] | 0.001 |
 LVEF (LVEF n/mb vs. LVEF > 30 %) | 6.24 [3.56–10.9] | <0.0001 | 5.04 [3.12–8.16] | <0.0001 | 5.49 [3.54–8.50] | <0.0001 |
 History of hyperlipidemia (yes vs. no) | 0.52 [0.32–0.85] | 0.01 | n/ac | 0.51 [0.35–0.74] | 0.001 | |
 History of COPD (yes vs. no) | 2.57 [1.05–6.32] | 0.04 | 2.11 [1.16–3.85] | 0.01 | n/ac | |
 Peak serum CPK level (U/l) (continuous) | 1.00 [1.00–1.00] | 0.001 | n/ac | 1.00 [1.00–1.00] | 0.005 | |
BBB (n = 330) | (n = 53) | (n = 111) | (n = 165) | |||
 Prior MI (yes vs. no) | 9.18 [1.62–51.9] | 0.01d | 3.17 [1.10–9.12] | 0.03 | n/ac | |
 Renal dysfunction (yes vs. no) | 18.8 [1.04–340.0] | 0.05d | n/ac | n/ac | ||
 History of hypertension (yes vs. no) | 0.11 [0.02–0.68] | 0.02d | n/ac | n/ac | ||
 LVEF (LVEF ≤ 30 % vs. LVEF > 30 %) | N/Ae | 2.41 [0.65–8.99] | 0.19 | 1.14 [0.46–2.83] | 0.79 | |
 LVEF (LVEF n/mb vs. LVEF > 30 %) | N/Ae | 10.5 [3.27–33.7] | <0.0001 | 9.44 [3.89–22.9] | <0.0001 | |
 Peak serum CPK level (U/l) (continuous | n/ac | n/ac | 1.00 [1.00–1.00] | 0.01 |